1. A surgical tool comprising:
a first link having a distal end, a proximal end, and a first link axis defined there between;
a joint coupled to the distal end of the first link;
a second link coupled to the joint, the joint being configured to orient the second link relative to the first link about a first axis and a second axis, the first and second axes being nonparallel to the first link axis, the first axis being nonparallel to the second axis;
four attachment features disposed on the second link; and
four tension members extending distally from the first link and arranged around the first link axis in a first diagonally opposed pair and a second diagonally opposed pair, each of the tension members being coupled to a respective one of the attachment features, each of the tension members being under tension induced by a force applied to the tension member and transferred to the respective one of the attachment features by the tension member,
wherein a first proximal movement along the first link axis of one tension member of the first diagonally opposed pair reorients the second link relative to the first link and produces a first distal movement along the first link axis of the other tension member of the first diagonally opposed pair,
wherein a second proximal movement along the first link axis of one tension member of the second diagonally opposed pair reorients the second link relative to the first link and produces a second distal movement along the first link axis of the other tension member of the second diagonally opposed pair, and
wherein interface surfaces between the tension members and the attachment features vary positions of the tension members relative to the second link in correlation with angular orientations of the second link relative to the first link so that the first proximal movement is equal in magnitude to the first distal movement and the second proximal movement is equal in magnitude to the second distal movement.
2. The tool of claim 1, wherein the first and second axes are non-intersecting.
3. The tool of claim 2, wherein each of the tension members pivots about a first associated center relative to a corresponding attachment feature when the second link pivots about the first axis, and wherein each of the tension members pivots about a second associated center relative to the corresponding attachment feature when the second link pivots about the second axis, and wherein the second associated center is axially displaced from the first associated center.
4. The tool of claim 3, wherein the tension members slidingly engage the attachment features, and wherein the interface surfaces comprise curving cylindrical surfaces having circular cross sections and curving interface axes, the circular cross sections defining cross sectional centers and the curving interface axes defining centers of curvature, each of the first associated center and the second associated center corresponding to a cross sectional center or a center of curvature.
5. The tool of claim 2, wherein the first and second axes are separated by 2 mm or less.
6. The tool of claim 1, wherein the first axis is perpendicular to the first link axis and the second axis is perpendicular to the first axis.
7. The tool of claim 1, wherein:
each of the attachment features comprises a curved portion; and
each of the tension members comprises an attachment lug configured to slidingly receive one of the curved portions so as to slide against and along the curved portion when the second link pivots about one of the first and second axes.
8. The tool of claim 7, wherein each of the curved portions comprises:
a curved centerline that lies in a plane perpendicular to the first axis or the second axis; and
a first radius of curvature about the curved centerline and a fixed center of curvature for the curved centerline.
9. The tool of claim 8, wherein each of the fixed centers of curvature lies in a plane containing at least one of the first axis or the second axis.
10. The tool of claim 8, wherein each of the curved centerlines is tangent to a plane containing at least one of the first axis or the second axis.
11. The tool of claim 1, wherein each of the attachment features comprises an attachment lug.
12. The tool of claim 11, wherein each of the attachment lugs has a connection hole axis oriented parallel to the first axis or the second axis.
13. The tool of claim 12, wherein each connection hole axis lies in a plane containing at least one of the first axis or the second axis.
14. The tool of claim 11, wherein each of the tension members comprises a curved portion configured to be slidingly received by one of the attachment lugs so that the curved portion slides within the attachment lug when the second link pivots about one of the first and second axes.
15. The tool of claim 1, wherein:
each of the attachment features is offset from the first and second axes when viewed along the first link axis, one of the attachment features being disposed in each quadrant defined by the first and second axes when viewed along the first link axis; and
the first diagonally opposed pair of the tension members is actuated by at least one cable extending from a first tension member of the first diagonally opposed pair to a second tension member of the first diagonally opposed pair, the at least one cable being wrapped around a first capstan, wherein varying positions of the first diagonally opposed pair of the tension members relative to the second link inhibits variations in tension of the at least one cable which would be imposed if the tension members were coupled to the attachment features with spherical center joints.
16. The tool of claim 15, wherein the second diagonally opposed pair of the tension members is actuated by at least one cable extending from a first tension member of the second diagonally opposed pair to a second tension member of the second diagonally opposed pair, the at least one cable being wrapped around a second capstan, wherein varying positions of the second diagonally opposed pair of the tension members relative to the second link inhibits variations in tension of the at least one cable which would be imposed if the tension members were coupled to the attachment features with spherical center joints, the second capstan being different from the first capstan.
17. A surgical tool comprising:
a first link having a distal end, a proximal end, and a first link axis defined between the distal end and the proximal end;
an intermediate member pivotally coupled to the distal end of the first link to rotate relative to the first link about a first axis;
a plurality of tension members extending distally from a control cable actuation assembly disposed adjacent the proximal end of the first link, each of the plurality of tension members being under tension induced by a force applied to the tension member by the control cable actuation assembly;
a second link coupled to the intermediate member to rotate relative to the intermediate member about a second axis, the first and second axes being nonparallel to the first link axis, the first axis being nonparallel to the second axis; and
a plurality of interface assemblies, each interface assembly of the plurality of interface assemblies coupling a corresponding one of the plurality of tension members with the second link so that axial movement of the tension members angularly orients the second link relative to the first link about the first and second axes, each of the plurality of tension members transferring the force applied to the tension member by the control cable actuation assembly to the corresponding one of the plurality of interface assemblies, a first one of the interface assemblies comprising a curved portion and an attachment lug having an attachment lug hole sized to slidingly receive the curved portion, wherein the attachment lug rotates about the curved portion when the second link rotates around the first axis and slides against and along the curved portion when the second link rotates around the second axis.
18. The tool of claim 17, wherein the plurality of tension members comprises four tension members.
19. A surgical instrument comprising:
a first link;
an intermediate member coupled to the first link;
a second link coupled to the intermediate member and comprising an attachment feature, wherein the attachment feature comprises a curved portion, wherein the intermediate member is constrained to rotate around a first axis that is fixed relative to the first link and the second link is constrained to rotate around a second axis that is fixed relative to the intermediate member, and wherein the first and second axes are non-parallel to and offset from one another; and
a tension member comprising an attachment lug, wherein the attachment lug is coupled to the attachment feature, wherein the attachment lug rotates around the curved portion when the tension member rotates the joint around the first axis, and wherein the attachment lug slides against and along the curved portion to maintain the tension member in tension when the tension member rotates the joint around the second axis, the tension member being under tension induced by a load applied to the tension member and transferred to the attachment feature by the tension member.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound of formula I:
or a pharmaceutically acceptable salt thereof, wherein:
W is selected from nitrogen, CH, or CF;
X is selected from CH or CF;
Z is O or NH;
R1 is phenyl or a 5-6 membered heteroaryl ring having 1-3 heteroatoms independently selected from oxygen, nitrogen, or sulfur, wherein:
R1 is substituted with 0-3 groups independently selected from -(T)y-Ar, R\u2032, oxo, C(O)R\u2032, CO2R\u2032, OR\u2032, N(R\u2032)2, SR\u2032, NO2, halogen, CN, C(O)N(R\u2032)2, NR\u2032C(O)R\u2032, SO2R\u2032, SO2N(R)2, or NR\u2032SO2R\u2032;
y is 0 or 1;
T is a straight or branched C1-4 alkylidene chain, wherein one methylene unit of T is optionally replaced by \u2014O\u2014, \u2014NH\u2014, or \u2014S\u2014;
each R\u2032 is independently selected from hydrogen, C1-4 aliphatic, or a 5-6 membered saturated, unsaturated, or aryl ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, wherein:
R\u2032 is substituted with 0-3 groups independently selected from halogen, oxo, Ro, N(Ro)2, ORo, CO2Ro, NRoC(O)Ro, C(O)N(Ro)2, SO2Ro, SO2N(Ro)2, or NRo, SO2Ro, wherein:
each Ro is independently selected from hydrogen, C1-4 aliphatic, or a 5-6 membered saturated, unsaturated, or aryl ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, and wherein:
two substituents on adjacent positions of R1 may be taken together to form a 5-7 membered saturated, partially unsaturated, or aryl ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur;
Ar is a 3-8 membered saturated, unsaturated, or aryl ring, a 3-7 membered heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5-6 membered heteroaryl ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, wherein:
Ar is substituted with 0-3 groups independently selected from R\u2032, oxo, CO2R\u2032, OR\u2032, N(R\u2032)2, SR\u2032, NO2, halogen, CN, C(O)N(R\u2032)2, NR\u2032C(O)R\u2032, SO2R\u2032, C(O)R\u2032, SO2N(R\u2032)2, or NR\u2032SO2R\u2032;
R2 is selected from hydrogen or a C1-3 aliphatic group; and
Ring A is a 5-6 membered heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, provided that said ring has a hydrogen-bond acceptor in the position adjacent to the point of attachment to Ring B, wherein:
Ring A is substituted with 0-3 groups independently selected from R\u2032, oxo, CO2R\u2032, OR\u2032, N(R\u2032)2, SR\u2032, NO2, halogen, CN, C(O)N(R\u2032)2, NR\u2032C(O)R\u2032, SO2R\u2032, SO2N(R\u2032)2, or NR\u2032SO2R\u2032, and wherein:
two substituents on adjacent positions of Ring A may be taken together to form a 5-7 membered saturated, partially unsaturated, or aryl ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur.
2. The compound according to claim 1, wherein Ring A is selected from the following optionally substituted rings:
3. The compound according to claim 2, wherein Ring A is an optionally substituted ring selected from rings a, f, l, s, w, y, or z:
4. The compound according to claim 1, wherein:
R1 is selected from an optionally substituted phenyl or 5-6 membered heteroaryl ring having 1-2 nitrogens.
5. The compound according to claim 4, wherein R1 is an optionally substituted ring selected from pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrimidin-6-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, or imidazol-5-yl.
6. The compound according to claim 5, wherein R1 is substituted with 0-2 groups independently selected from halogen, oxo, R\u2032, CO2R\u2032, OR\u2032, N(R\u2032)2, SR\u2032, C(O)N(R)2, NR\u2032C(O)R\u2032, SO2R\u2032, SO2N(R\u2032)2, or NR\u2032SO2R\u2032.
7. The compound according to claim 6, wherein R2 is selected from methyl, ethyl, isopropyl, or cyclopropyl.
8-16. (canceled)
17. The compound according to claim 1, wherein said compound is of formula
or a pharmaceutically acceptable salt thereof.
18. (canceled)
19. The compound according to claim 1 wherein R2 is ethyl.
20. A compound selected from the group consisting of:
and I-295.
21. A composition comprising a compound according to claim 1, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
22-24. (canceled)
25. A method of inhibiting gyrase and TopoIV activity in a patient, comprising the step of contacting said patient with a composition according to claim 21.
26. A method of decreasing bacterial quantity in a patient, comprising the step of administering to said patient a composition according to claim 21.
27. A method of treating, preventing, or lessening the severity of, a bacterial infection in a patient, comprising the step of administering to said patient a composition according to claim 21.
28. The method according to claim 27, wherein the bacterial infection to be treated is characterized by the presence of one or more of the following: Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae, Enterobacter sps. Proteus sps. Pseudomonas aeruginosa, E. coli, Serratia marcesens, Staphylococcus aureus, Coag. Neg. Staph, Haemophilus influenzae, Bacillus anthracis, Mycoplasma pneumoniae, Moraxella catarralis, Chlamydia pneumoniae, Legionella pneumophila, Staphylococcus epidermidis, Mycobacterium tuberculosis, or Helcoibacter pylori.
29. The method according to claim 28, wherein the bacterial infection to be treated is selected from one or more of the following: a urinary tract infection, a respiratory infection, pneumonia, prostatitis, a skin or soft tissue infection, an intra-abdominal infection, a blood stream infection, or an infection of febrile neutropenic patients.
30. The method according to claim 29, further comprising the step of administering to said patient an additional therapeutic agent either as part of a multiple dosage form together with said compound or as a separate dosage form.
31. (canceled)